Uptake of HCV Therapy in HIV/HCV Coinfected Patients across Europe in the Era of Direct-Acting Antivirals

被引：0
|
作者：
Peters, Lars [1 ]
机构：
[1] Univ Copenhagen, Rigshosp, Dept Infect Dis, CHIP, Copenhagen, Denmark
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1954
引用
收藏
页码：969A / 969A
页数：1
相关论文
共 50 条
  • [41] Impact of Direct-Acting Antivirals on the Outcome of HIV/HCV Coinfected Patients with Non-Hodgkin Lymphomas in the Modern AntiRetroviral Therapy Era: A Retrospective Multicenter Study of 74 Cases
    Merli, Michele
    Re, Alessandro
    Bibas, Michele
    Dalu, Davide
    Ravano, Emanuele
    Gini, Guido
    Visco, Carlo
    Tisi, Maria Chiara
    Cencini, Emanuele
    Marino, Dario
    Gentile, Massimo
    Sciarra, Roberta
    Rovelli, Cristina
    Zuccaro, Valentina
    Mazzotta, Valentina
    Fasola, Cinzia
    Zilioli, Vittorio Ruggero
    Fraenza, Costanza
    Bianchi, Benedetta
    Daffini, Rosa
    Pinnetti, Carmela
    Stocchetti, Benedetta Lombardi
    Mora, Barbara
    Cristinelli, Caterina
    Grossi, Paolo
    Passamonti, Francesco
    Spina, Michele
    Arcaini, Luca
    BLOOD, 2021, 138
  • [42] Direct-acting antivirals for paediatric HCV: we got there
    Sokal, Etienne M.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (08) : 452 - +
  • [43] Mortality associated with the treatment of HCV with direct-acting antivirals
    Laurain, Anne
    Kramer, Laura
    Sultanik, Philippe
    Vallet-Pichard, Anais
    Sogni, Philippe
    Pol, Stanislas
    GUT, 2018, 67 (01) : 197 - +
  • [44] Direct-acting antivirals for paediatric HCV: we got there
    Etienne M. Sokal
    Nature Reviews Gastroenterology & Hepatology, 2017, 14 : 452 - 453
  • [45] Adverse outcomes with direct-acting antivirals for HCV infections
    Reactions Weekly, 2019, 1758 (1) : 4 - 4
  • [46] Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection
    Collins, Lauren F.
    Chan, Austin
    Zheng, Jiayin
    Chow, Shein-Chung
    Wilder, Julius M.
    Muir, Andrew J.
    Naggie, Susanna
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (01):
  • [47] Changes in the Lipid Asset of HIV/HCV Patients after a Successful Course of Direct-Acting Antivirals
    Spera, Anna Maria
    Conti, Valeria
    Corbi, Graziamaria
    Ascione, Tiziana
    Ciccarelli, Michele
    Masullo, Alfonso
    Franci, Gianluigi
    Pagliano, Pasquale
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
  • [48] Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
    Poizot-Martin, Isabelle
    Naqvi, Alissa
    Obry-Roguet, Veronique
    Valantin, Marc-Antoine
    Cuzin, Lise
    Billaud, Eric
    Cheret, Antoine
    Rey, David
    Jacomet, Christine
    Duvivier, Claudine
    Pugliese, Pascal
    Pradat, Pierre
    Cotte, Laurent
    PLOS ONE, 2015, 10 (10):
  • [49] Challenges faced by direct acting antivirals (DAA) against HCV in the current HIV/HCV-coinfected population in Spain
    Poveda, E.
    Vispo, E.
    Barreiro, P.
    de Mendoza, C.
    Labarga, P.
    Soriano, V.
    ANTIVIRAL THERAPY, 2011, 16 : A90 - A90
  • [50] Effectiveness and safety of direct-acting antiviral therapies (DAA) in cirrhotic HCV monoinfected and HIV/HCV coinfected patient
    Carmona, Pilar
    Von Wichmann, Miguel Angel
    Arenas, Juan Ignacio
    Esandi, Francisco
    Rodriguez-Arrondo, Francisco
    Gayan, Maria Jesus
    Martin, Leticia
    Iribarren, Jose A.
    HEPATOLOGY, 2016, 64 : 991A - 991A
12345